Navigation Links
American Society for Microbiology honors Adrian M. Zelazny
Date:7/14/2008

Washington, DCMay 28, 2008The 2008 American Society for Microbiology (ASM) Siemens Healthcare Diagnostics Young Investigator Award is being presented to Adrian M. Zelazny, Staff Scientist, Laboratory of Clinical Infectious Diseases, NIAID, National Institutes of Health (NIH). This award recognizes outstanding applied research in clinical microbiology or antimicrobial therapy.

Dr. Zelazny is honored for his work studying infection susceptibility and resistance, microbial virulence, and host/pathogen interactions at the NIH. Dr. Zelazny came to the NIH in 2003 on a Fogarty International Center Fellowship. As a Fellow, he developed a method using PCR assay to detect and identify Leishmania species in patient specimens, and was recognized for this work with the NIH Fellow's Award for Research Excellence in 2005. Dr. Zelazny is currently directing a project to use this assay method to detect and identify Mycobacteria and Nocardia species. In 2007, he received a NIH Director's Science Group Award for his role in the discovery of Granulobacter bethesdensis, and he has applied for a patent as co-inventor for the method of detection and identification of Mycobacterium using SecA.

Dr. Zelazny received his B.S. in Clinical Biochemistry from the University of Buenos Aires, Argentina, and his Ph.D. degree in Biochemistry from the Weizmann Institute of Science, Rehovot, Israel.

The Siemens Healthcare Diagnostics Young Investigator Award will be presented during the 108th General Meeting of the American Society for Microbiology (ASM), June 1 June 5, 2008 in Boston, Massachusetts. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
Breaking Biology Technology: